Our second interview of May takes us to our US headquarters, where we had the pleasure of speaking with Rebekah, Clinical Trials Assistant.
What is your role at GCT, and how long have you been with the company?
I am a Clinical Trials Assistant. I joined Global Clinical Trials team on June 30, 2025.
What does a typical day look like for you in your current position?
My day involves supporting clinical operations, ensuring regulatory compliance, and managing the documentation essential for our trials to run smoothly.
What is your favorite part about working in clinical research?
I appreciate the structured nature of the work and the knowledge that our accuracy directly impacts the safety and efficacy of new treatments.
What do you think sets GCT apart from other companies in the industry?
GCT has a long-standing reputation—celebrating 25 years—and maintains a focused, high-quality approach to clinical research.
What do you think is the most important quality for someone in your field to have?
Attention to detail and a strong understanding of regulatory standards are vital for maintaining the integrity of clinical data.
What is the most rewarding aspect of being part of GCT?
It is rewarding to be part of a team that has spent over a quarter-century building trust within the life sciences sector.
How do you stay motivated and engaged in your daily work?
I am motivated by the constant evolution of the industry and the opportunity to apply my background in chemistry and management to complex projects.
What is a professional achievement you’re particularly proud of?
I am proud of successfully transitioning into the clinical research operations side of the industry and completing my certifications in data analysis and operations.
What is the biggest challenge facing the clinical research industry today?
The industry is currently navigating the integration of new technologies, like AI and automated workflows, while maintaining strict compliance standards.
In honor of GCT’s 25th anniversary, what is one wish you have for the company’s future?
I wish for the company to continue its steady growth and remain a trusted partner in the global clinical trials landscape for another 25 years.